Previous studies have shown that miR-125b suppresses NF-κB activation through direct targeting of TRAF6 in sepsis [35] and promotes inflammation via A20 inhibition in rheumatoid arthritis [20]. This evidence concerns the gene TRAF6 and Sepsis.